TRACY REESE: Open Payments
NPI 1295824795 · KALAMAZOO, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$443 in 21 payments from 11 companies in 2025. Trend: 2023 $689 · 2024 $819 · 2025 $443
Food & beverage: $443
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $107 |
| Novartis Pharmaceuticals Corporation | 5 | $79 |
| E.R. Squibb & Sons, L.L.C. | 4 | $73 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $35 |
| GlaxoSmithKline, LLC. | 2 | $29 |
| AtriCure, Inc. | 1 | $27 |
| PFIZER INC. | 1 | $26 |
| Alnylam Pharmaceuticals Inc. | 1 | $24 |
| BridgeBio Pharma, Inc. | 1 | $18 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $15 |
Products named: REPATHA, LEQVIO, CAMZYOS, Kerendia, ELIQUIS, ATRICLIP LAA EXCLUSION SYSTEM, VYNDAQEL, ONPATTRO.
Industry payments across MI — which companies pay providers there.
